Zhongke Guosheng
中科国生
Zhongke Guosheng (中科国生, also known as GS Biotech) is a Hangzhou-based biotech company developing functional bio-based new materials built around the 5-hydroxymethylfurfural (HMF) platform compound . The company raised tens of millions of RMB in an angel round in November 2021, co-led by 5Y Capital and Legend Capital, with Yayi Capital also participating . 5Y Capital later added to its position in subsequent rounds, including a nearly RMB 100 million Pre-A round led by Legend Capital in late 2022 and a RMB 200 million A+ round in March 2025 . The 2025 financing was led by CITIC Jinshi and Puhua Capital, with existing shareholders including 5Y Capital and Legend Capital continuing to invest .
AI-generated — may contain errors, please verify.
Coverage
April: Curiosity and New Paths | 5Y News Monthly
The big news from last month.
五源资本·January: Toward Broader Horizons | 5Y News Monthly
The big news from last month.
五源资本·5Y News | 5Y Capital Portfolio Company "Zhongke Guosheng" Closes Nearly RMB 100 Million Pre-A Round
Accelerate the development of China's bio-based materials industry.
五源资本·December, Everything Within Reach | 5Y News Monthly
The big news from last month.
五源资本·5Y News | "中科国生" Raises Tens of Millions of RMB in Angel Round to Develop and Promote Functional Bio-based New Materials
Transforming lives with biomass.
五源资本·
